Notebook

CHANGES INSTITUTED: With the status change complete, director Francis Collins says he’s now working on setting new goals. Rumors that had been flying around the National Institutes of Health in early January about a status change for the National Center for Human Genome Research (NCHGR) (S. Benowitz, The Scientist, Jan. 20, 1997, page 1) turned out to be true. On January 14, NCHGR officially became the National Human Genome Research Institute (NHGRI). Except for some added flexibility in

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

CHANGES INSTITUTED: With the status change complete, director Francis Collins says he’s now working on setting new goals. Rumors that had been flying around the National Institutes of Health in early January about a status change for the National Center for Human Genome Research (NCHGR) (S. Benowitz, The Scientist, Jan. 20, 1997, page 1) turned out to be true. On January 14, NCHGR officially became the National Human Genome Research Institute (NHGRI). Except for some added flexibility in awarding grants, the fact that the center has become an institute changes little, according to director Francis Collins. "This is a recognition that NCHGR has [already] been operating effectively as an institute" because of its intramural research program and research award-granting authority, he says. Collins also sees the new status as lending "a sense of permanence" to the Human Genome Project (HGP), the 15-year, $3 billion international effort to locate and sequence ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies